A CLINICAL-STUDY ON THE USE OF CODEINE, OXYCODONE, DEXTROPROPOXYPHENE, BUPRENORPHINE, AND PENTAZOCINE IN CANCER PAIN

被引：30

作者：

DECONNO, F ^{[1
]}

RIPAMONTI, C ^{[1
]}

SBANOTTO, A ^{[1
]}

BARLETTA, L ^{[1
]}

ZECCA, E ^{[1
]}

MARTINI, C ^{[1
]}

VENTAFRIDDA, V ^{[1
]}

机构：

[1] NATL CANC INST,DIV PAIN THERAPY & PALLIAT CARE,VIA VENEZIAN 1,I-20133 MILAN,ITALY

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1991年 / 6卷 / 07期

关键词：

OPIOIDS; PAIN RELIEF; SIDE EFFECTS; DOSAGE; DURATION OF TREATMENT;

D O I：

10.1016/0885-3924(91)90040-B

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The authors report a prospective study on 944 cancer pain patients treated with one of the following opioids: codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine. Level of analgesia, duration of treatment, side effects, and drop out were evaluated for each drug. Twenty-four percent of the patients still benefitted from treatment at the fourth week of study, even if high drug dosages were not used. Pentazocine did not show an evident analgesic effect during the first 2 wk of treatment. The other opioids were found to be valid therapeutic instruments for chronic cancer pain control in a limited number of patients.

引用

页码：423 / 427

页数：5

共 50 条

[21] SUB-LINGUAL BUPRENORPHINE VERSUS INTRAMUSCULAR PENTAZOCINE IN POSTOPERATIVE PAIN THERAPY - A RANDOMIZED, STANDARDIZED STUDY
TOLKSDORF, W
BANGERT, J
SCHMIDT, R
ANAESTHESIST, 1982, 31 (09): : 486 - 486
[22] Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain
Wiffen, Philip J.
Derry, Sheena
Moore, R. Andrew
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
[23] Laxative Use in Inpatients on Oxycodone/Naloxone Prolonged Release and Oxycodone Prolonged Release for Cancer and Non-cancer Pain
Patel, Joanne
Lucas, Catherine J.
Margalit, Maxwell
Martin, Jennifer H.
JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2018, 32 (2-3) : 116 - 123
[24] CLINICAL-STUDY OF GASTRIC-CANCER
PAUSAWASDI, A
SUNTHARABHA, S
TANWATCHARABHAN, P
PAUSAWASDI, S
JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1980, 63 (12): : 655 - 661
[25] CLINICAL-STUDY WITH DIFLUNISAL IN THE TREATMENT OF TUMOR-PAIN
SEINFELD, H
BRAUN, HD
FORTSCHRITTE DER MEDIZIN, 1982, 100 (45) : 2132 - 2134
[26] LOW-BACK-PAIN - A PSYCHOSOMATIC CLINICAL-STUDY
VILLARD, HP
IMBEAULT, J
DUGUAY, M
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1986, 45 (02) : 78 - 83
[27] LOW-BACK-PAIN - A PSYCHOSOMATIC CLINICAL-STUDY
DUGUAY, M
IMBEAULT, J
VILLARD, HP
UNION MEDICALE DU CANADA, 1985, 114 (02): : 122 - +
[28] When Buprenorphine is Not Enough: A Case of Transitioning Off of Buprenorphine in Cancer Pain and Opioid Use Disorder
Kelly, Lauren
Ahmed, Ebtesam
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E757 - E758
[29] The Use of High Dosages of Transdermal Buprenorphine for Pain Management in Palliative Cancer Patients: A Case Study
Clement, Paul M. J.
Beuselinck, Benoit
Van Beek, Karen
Mertens, P. Georgette
Cornelissen, Paul
Menten, Johan
CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 169 - 173
[30] HOW TO USE STANDARD ERROR IN A CLINICAL-STUDY
DAVIS, RH
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1987, 77 (03): : 154 - 156

← 1 2 3 4 5 →